These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36711835)

  • 1. The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses.
    Soni M; Migliori E; Fu J; Assal A; Chan HT; Pan J; Khatiwada P; Ciubotariu R; May MS; Pereira M; De Giorgi V; Sykes M; Mapara MY; Muranski P
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses.
    Soni MK; Migliori E; Fu J; Assal A; Chan HT; Pan J; Khatiwada P; Ciubotariu R; May MS; Pereira MR; De Giorgi V; Sykes M; Mapara MY; Muranski PJ
    Front Immunol; 2023; 14():1212203. PubMed ID: 37901229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
    Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM
    Front Immunol; 2022; 13():954093. PubMed ID: 36159791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection.
    Soni M; Migliori E; Assal A; Chan HT; Ciubotariu R; Pan JB; Cicero K; Pereira M; Mapara MY; Muranski P
    Cytotherapy; 2021 Nov; 23(11):980-984. PubMed ID: 34183244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2.
    Woldemeskel BA; Kwaa AK; Garliss CC; Laeyendecker O; Ray SC; Blankson JN
    J Clin Invest; 2020 Dec; 130(12):6631-6638. PubMed ID: 32966269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
    Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
    Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Non-SARS-CoV2 Human Coronaviruses (HCoVs) in People Presenting with Influenza-like Illness (ILI) or Severe Acute Respiratory Infections (SARI) in Senegal from 2012 to 2020.
    Faye MN; Barry MA; Jallow MM; Wade SF; Mendy MP; Sy S; Fall A; Kiori DE; Ndiaye NK; Goudiaby D; Diamanka A; Niang MN; Dia N
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study.
    Sealy RE; Hurwitz JL
    Microorganisms; 2021 Jul; 9(8):. PubMed ID: 34442723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.
    Steiner S; Sotzny F; Bauer S; Na IK; Schmueck-Henneresse M; Corman VM; Schwarz T; Drosten C; Wendering DJ; Behrends U; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2020; 11():607918. PubMed ID: 33424856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.
    Hu C; Wang Z; Ren L; Hao Y; Zhu M; Jiang H; Wang S; Li D; Shao Y
    Front Cell Infect Microbiol; 2022; 12():978440. PubMed ID: 36118022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines.
    Joseph JO; Ylade M; Daag JV; Aogo R; Crisostomo MV; Mpingabo P; Premkumar L; Deen J; Katzelnick L
    Res Sq; 2023 Nov; ():. PubMed ID: 38014070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview on the seven pathogenic human coronaviruses.
    Kesheh MM; Hosseini P; Soltani S; Zandi M
    Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63.
    Woldemeskel BA; Garliss CC; Blankson JN
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33822770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of four endemic human coronaviruses and, reactivity and neutralization capability against SARS-CoV-2 among children in the Philippines.
    Sayama Y; Okamoto M; Saito M; Saito-Obata M; Tamaki R; Joboco CD; Lupisan S; Oshitani H
    Sci Rep; 2023 Feb; 13(1):2310. PubMed ID: 36759702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms.
    Cantoni D; Siracusano G; Mayora-Neto M; Pastori C; Fantoni T; Lytras S; Di Genova C; Hughes J; On Behalf Of The Ambulatorio Medico San Luca Villanuova Group ; Lopalco L; Temperton N
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
    Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
    bioRxiv; 2022 Dec; ():. PubMed ID: 36482973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-existing Immunity to Endemic Human Coronaviruses Does Not Affect the Immune Response to SARS-CoV-2 Spike in a Murine Vaccination Model.
    Jeong AY; Lee P; Lee MS; Kim DJ
    Immune Netw; 2023 Apr; 23(2):e19. PubMed ID: 37179748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2.
    Denninger V; Xu CK; Meisl G; Morgunov AS; Fiedler S; Ilsley A; Emmenegger M; Malik AY; Piziorska MA; Schneider MM; Devenish SRA; Kosmoliaptsis V; Aguzzi A; Fiegler H; Knowles TPJ
    ACS Infect Dis; 2022 Apr; 8(4):790-799. PubMed ID: 35352558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.